Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

HCW Biologics Secures $26.25M Non-Dilutive Financing With Asset-Backed Development Loan

Author: Benzinga Newsdesk | April 27, 2023 07:46am

This five-year, non-amortizing loan, collateralized with real estate assets, provides project financing for the buildout of the Company's new headquarters and manufacturing facility.

Posted In: HCWB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist